Demedicalizing Depression: An Interview with Milutin Kostić

8
Justin Karter interviews Milutin Kostić on the fundamental flaws in depression research and its neglect of human complexity.

Youth Antipsychotic Use Linked to Increased Risk of Death within Five Years

3
Those aged 18-24 had an increased risk of death within five years on doses above 100 mg chlorpromazine equivalents.

Remembering Bhargavi Davar: A Global Leader in the Struggle for Human Rights

3
Bhargavi Davar was a global leader in the struggle for human rights, with her work as a psychiatric survivor activist simply one aspect of that work.

Involuntary Hospitalization Increases Risk of Suicide, Study Finds

24
New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

Long-term Outcomes Better for Those Who Stop Taking Antipsychotics

14
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.

Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain

90
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

22
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.
Young man refusing to take prescribed pills in clinic

Antipsychotics Lead to Worse Outcomes in First-Episode Psychosis

23
Those who did not get antipsychotics in the first month were almost twice as likely to be in recovery after five years.

Psychiatric Drugs Do Not Improve Disease or Reduce Mortality

56
Nassir Ghaemi: “Most psychiatric medications are purely symptomatic, with no known or proven effect on the underlying disease. They are like 50 variations of aspirin, used for fever or headache, rather than drugs that treat the causes of fever or headache.”
3D render of placebo pills isolated over wood background

Placebo Effect—Not Antidepressants—Responsible for Depression Improvement

15
In adolescent depression treatment, those who received a placebo but thought they received Prozac improved more than those who received the drug and knew it.

Antidepressants No Better Than Placebo for About 85% of People

25
Researchers can’t predict the 15% who benefit from antidepressants, and the other 85% are unnecessarily exposed to the harms of the drugs.

Antiseizure Drug Exposure in Pregnancy Linked to Large Risk of Autism, ADHD, and Intellectual...

3
Harms are “largely overlooked by psychiatry despite widespread usage,” according to the researchers.

Robin Williams On Antidepressant at Time of Suicide

39
Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...

Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients: Interview with Psychiatrist Swapnil Gupta

13
Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

Wunderink: Antipsychotics Can Be Tapered Safely Without Increasing Relapse Risk

7
Tapering antipsychotics slowly and with supported decision-making may improve care for patients with psychosis.

Case Studies Reveal Patient Empowerment Through Tapering Antipsychotics

1
A new study shows how different patients respond to tapering antipsychotic medication under expert guidance, highlighting personal empowerment and the complexities of withdrawal.

Long-Term Benzo Use Linked to Increased Disability

0
Despite guidance that the drugs should only be used short-term, about a third of patients indicated long-term benzo use.

Study Highlights Difficulty of Antipsychotic Withdrawal

0
New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.

Antidepressant Use Tightly Correlates with Increased Suicide Rates

4
While the study can’t confirm causality, it does contradict the notion that antidepressants reduce suicide at the population level.

When Medication Changes More Than Symptoms: Antipsychotics’ Effect on Identity

10
Recent research reveals how antipsychotic medications can significantly impact users' identity and self-image, challenging existing clinical approaches.

Recovery Rate Six Times Higher For Those Who Stop Antipsychotics Within Two Years

62
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.

Study Links Prenatal Antipsychotic Exposure to Developmental Delays and ADHD

1
A comprehensive review indicates that children exposed to antipsychotics in the womb face an increased risk of ADHD and developmental delays.

Hyperbolic Tapering off Antidepressants Limits Withdrawal

6
New research by Jim van Os and Peter Groot finds that using hyperbolic tapering to discontinue antidepressants reduces withdrawal effects.

Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?

1
Research sheds light on the impact of antidepressants on sexual dysfunction, emphasizing the need for patient-physician communication.
3D illustration of a matrix with tablets and the words risks and benefits. Concept of clinical trials results

Two Out of Three Find Antidepressant Effects Not Worth Burdens

1
New study reveals: 2 in 3 people need more than the current antidepressant benefits to consider them worthwhile.